analyzed the association between serum and salivary NLRP3 concentrations in patients with periodontitis and type-II diabetes mellitus through a clinical trial, and found that NLRP3 had demonstrated a promising biomarker of disease risk in patients with periodontitis and type-II diabetes mellitus. The gene discussed is NLRP3; the disease is periodontitis.